4-bromo-7H-pyrrolo(2,3-d)pyrimidine (CAS No: 889939-42-8) is a key pharmaceutical intermediate used in the synthesis of APIs Baricitinib, Tofacitinib and Ruxolitinib. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: 4-Bromo-7H-pyrrolo[2 pound not3-d]pyrimidine
CAS No: 889939-42-8
PubChem CID: 23260885
Mol Formula: C6H4BrN3
Mol Weight: 198.02 g/mol
Used in APIs: Baricitinib, Tofacitinib and Ruxolitinib
IUPAC Name: 4-bromo-7H-pyrrolo[2,3-d]pyrimidine
API Intermediate Description: 4-Bromo-7H-pyrrolo(2,3-d)pyrimidine is a crucial building block (intermediate) in medicinal chemistry, primarily used to synthesize pharmaceuticals like kinase inhibitors (e.g., for arthritis, cancer) and potential antibacterial/antifungal agents, leveraging its reactive bromine for cross-coupling reactions to build complex, biologically active molecules, including some pesticides and herbicides in agriculture.
